Yamagishi, GIP as a potential therapeutic target for atherosclerotic cardiovascular disease: a systematic review
Q: If someone never plans to take a GLP-1, what nutrition habits matter most for metabolic health and weight regulation
While it has a lower glycemic index than white sugar, it can still raise blood sugar levels, making it a less ideal choice for GLP-1 users seeking optimal blood sugar control
If you don't see adequate results after reaching the target dose and giving the medication sufficient time (typically 12 to 16 weeks at the maintenance dose), your provider may recommend switching to a different GLP-1 medication, adjusting your dose, or adding other interventions
Finally, this study evaluated pulmonary toxicity exclusively in male rats to minimize hormonal variability
These side effects are typically mild to moderate and are most common during the first few weeks of treatment or after a dose increase